Novavax reported $18.5M in Stock for its fiscal quarter ending in September of 2026.





Stock Change Date
Adma Biologics USD 266.12M 26.8M Sep/2026
AstraZeneca USD 6.93B 362M Jun/2026
BioCryst Pharmaceuticals USD 13.74M 7.68M Sep/2026
Geron USD 126.6M 3M Sep/2026
GlaxoSmithKline GBP 6.28B 125M Jun/2026
MannKind USD 48.47M 4.05M Sep/2026
Merck USD 6.16B 43M Sep/2026
Moderna USD 313M 33M Sep/2026
Novartis USD 6.1B 182M Sep/2026
Novavax USD 18.5M 8.49M Sep/2026
Pfizer USD 10.02B 77M Sep/2026
Sanofi EUR 24.12B 620M Jun/2026
Sarepta Therapeutics USD 876.12M 28.15M Sep/2026
TG Therapeutics USD 194.32M 46.35M Sep/2026